Yüklüyor......
Pioglitazone therapy for HIV/HAART-associated lipodystrophy syndrome could increase subcutaneous fat mass in non-lipoatrophic but not in lipoatrophic regions
Highly active antiretroviral therapy (HAART) is associated with multiple metabolic disorders, including lipodystrophy, dyslipidaemia and insulin resistance. HIV/HAART-associated lipodystrophy syndrome (HALS) is characterised by subcutaneous fat wasting, central fat accumulation and increased risk of...
Kaydedildi:
| Yayımlandı: | BMJ Case Rep |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4769467/ https://ncbi.nlm.nih.gov/pubmed/26917795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2015-213637 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|